Heparanase Promotes Syndecan-1 Expression to Mediate Fibrillar Collagen and Mammographic Density in Human Breast Tissue Cultured
NMR
breast cancer
heparanase
mammographic density
syndecan-1
Journal
Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250
Informations de publication
Date de publication:
2020
2020
Historique:
received:
22
04
2020
accepted:
19
06
2020
entrez:
8
8
2020
pubmed:
8
8
2020
medline:
8
8
2020
Statut:
epublish
Résumé
Mammographic density (MD) is a strong and independent factor for breast cancer (BC) risk and is increasingly associated with BC progression. We have previously shown in mice that high MD, which is characterized by the preponderance of a fibrous stroma, facilitates BC xenograft growth and metastasis. This stroma is rich in extracellular matrix (ECM) factors, including heparan sulfate proteoglycans (HSPGs), such as the BC-associated syndecan-1 (SDC1). These proteoglycans tether growth factors, which are released by heparanase (HPSE). MD is positively associated with estrogen exposure and, in cell models, estrogen has been implicated in the upregulation of HPSE, the activity of which promotes SDC expression. Herein we describe a novel measurement approach (single-sided NMR) using a patient-derived explant (PDE) model of normal human (female) mammary tissue cultured
Identifiants
pubmed: 32760722
doi: 10.3389/fcell.2020.00599
pmc: PMC7373078
doi:
Types de publication
Journal Article
Langues
eng
Pagination
599Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2020 Huang, Reye, Momot, Blick, Lloyd, Tilley, Hickey, Snell, Okolicsanyi, Haupt, Ferro, Thompson and Hugo.
Références
Breast Cancer Res. 2016 Jan 08;18(1):5
pubmed: 26747277
Cancer Microenviron. 2012 Aug;5(2):115-32
pubmed: 21811836
J Biol Chem. 2012 Mar 23;287(13):9952-61
pubmed: 22298773
PLoS One. 2009;4(4):e5181
pubmed: 19360105
Am J Epidemiol. 2009 Dec 15;170(12):1571-8
pubmed: 19910376
J Cell Biol. 2006 Sep 25;174(7):1097-106
pubmed: 16982797
Am J Epidemiol. 2015 Nov 15;182(10):863-7
pubmed: 26520360
J Natl Cancer Inst. 2014 Sep 12;106(10):
pubmed: 25217577
Cell. 2009 Nov 25;139(5):891-906
pubmed: 19931152
Hum Reprod. 2007 Apr;22(4):927-37
pubmed: 17261577
Front Endocrinol (Lausanne). 2018 Aug 24;9:483
pubmed: 30197623
Breast Cancer Res. 2016 Dec 1;18(1):120
pubmed: 27906044
Mol Cell Proteomics. 2012 Apr;11(4):M111.014647
pubmed: 22159717
Breast Cancer Res. 2015 Jun 04;17:79
pubmed: 26040322
Breast Cancer. 2017 Nov;24(6):742-747
pubmed: 28382590
Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1479-88
pubmed: 22956730
Cancer. 2009 Dec 15;115(24):5780-7
pubmed: 19902459
Breast Cancer Res Treat. 2011 Jul;128(2):505-16
pubmed: 21258862
Matrix Biol. 2014 Apr;35:215-22
pubmed: 24145151
Ann Intern Med. 1999 Feb 16;130(4 Pt 1):262-9
pubmed: 10068383
Mol Oncol. 2018 Sep;12(9):1608-1622
pubmed: 30117261
Oncotarget. 2017 Jan 17;8(3):5578-5591
pubmed: 27894075
Breast Cancer Res Treat. 2014 Nov;148(2):303-14
pubmed: 25332094
PLoS One. 2016 Feb 24;11(2):e0150132
pubmed: 26909794
Mol Vis. 2016 Apr 30;22:424-35
pubmed: 27168718
Climacteric. 2006 Aug;9(4):277-82
pubmed: 16857657
Clin Exp Metastasis. 2009;26(4):357-70
pubmed: 18766302
Int J Mol Sci. 2018 Feb 19;19(2):
pubmed: 29463044
J Mammary Gland Biol Neoplasia. 2015 Dec;20(3-4):121-31
pubmed: 26501889
J Natl Cancer Inst. 2010 Aug 18;102(16):1224-37
pubmed: 20616353
J Cell Biochem. 2015 Aug;116(8):1668-79
pubmed: 25735873
Equine Vet J. 2000 Mar;32(2):161-3
pubmed: 10743973
J Natl Cancer Inst. 2011 May 4;103(9):744-52
pubmed: 21483019
J Med Chem. 2012 Apr 26;55(8):3804-13
pubmed: 22458531
Breast. 2015 Oct;24(5):576-81
pubmed: 26071795
FEBS J. 2013 May;280(10):2207-15
pubmed: 23375101
Nat Genet. 2000 Jul;25(3):329-32
pubmed: 10888884
Oncotarget. 2017 Jun 27;8(26):43521-43535
pubmed: 28388549
J Biol Chem. 2007 May 18;282(20):14906-15
pubmed: 17344212
Breast Cancer Res Treat. 2019 Sep;177(2):251-276
pubmed: 31177342
Magn Reson Med. 2018 Sep;80(3):1243-1251
pubmed: 29399874
Maturitas. 2005 Feb 14;50(2):105-10
pubmed: 15653007
Breast Cancer Res. 2013 Nov 27;15(6):R113
pubmed: 24283570
Prostate. 2016 Aug;76(11):977-85
pubmed: 27062540
Magn Reson Imaging. 2019 Oct;62:111-120
pubmed: 31176808
Cancer Res. 2002 Sep 15;62(18):5210-7
pubmed: 12234986
Am J Pathol. 2011 Mar;178(3):1221-32
pubmed: 21356373
J Cancer Res Clin Oncol. 2003 Dec;129(12):735-6
pubmed: 14574570
Histochem J. 1997 Apr;29(4):317-27
pubmed: 9184847
Cancer Prev Res (Phila). 2020 Apr;13(4):411-422
pubmed: 31988145
BMC Med. 2008 Apr 28;6:11
pubmed: 18442412
Breast Cancer Res Treat. 2008 Apr;108(3):409-16
pubmed: 18351455
Cancer Res. 2003 Dec 15;63(24):8821-6
pubmed: 14695198
N Engl J Med. 2002 Sep 19;347(12):886-94
pubmed: 12239257
Oncotarget. 2017 Nov 30;8(67):111444-111455
pubmed: 29340066
Cold Spring Harb Perspect Biol. 2011 Jul 01;3(7):
pubmed: 21690215
Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2587-93
pubmed: 18086762
J Biol Chem. 2007 May 4;282(18):13326-33
pubmed: 17347152
J Natl Cancer Inst. 2017 Sep 1;109(9):
pubmed: 28376149
Am J Pathol. 2011 Jan;178(1):325-35
pubmed: 21224069
Cancer Causes Control. 2017 Dec;28(12):1429-1439
pubmed: 28965165
MethodsX. 2015 Feb 21;2:124-34
pubmed: 26150980
J Biol Chem. 2015 Jan 9;290(2):941-9
pubmed: 25404732
Breast Cancer Res Treat. 2014 Apr;144(3):479-502
pubmed: 24615497
Anticancer Res. 2005 Nov-Dec;25(6C):4743-6
pubmed: 16334170
Ann Intern Med. 2016 Feb 16;164(4):226-35
pubmed: 26756902
Magn Reson Med. 2019 Sep;82(3):1199-1213
pubmed: 31034648
J Cell Biol. 2012 Feb 20;196(4):395-406
pubmed: 22351925
Tumour Biol. 2015 Mar;36(3):1731-8
pubmed: 25361632
J Mol Cell Cardiol. 2015 Nov;88:133-44
pubmed: 26449522
Pharmacol Rev. 2009 Jun;61(2):198-223
pubmed: 19549927